Compare PASG & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PASG | PRSO |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 13.4M |
| IPO Year | 2020 | 2000 |
| Metric | PASG | PRSO |
|---|---|---|
| Price | $3.38 | $0.37 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | 15.5K | ★ 11.3M |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.23 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $14,573,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $191.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.99 |
| 52 Week Low | $3.29 | $0.36 |
| 52 Week High | $20.00 | $2.10 |
| Indicator | PASG | PRSO |
|---|---|---|
| Relative Strength Index (RSI) | 34.64 | 42.56 |
| Support Level | $3.29 | $0.36 |
| Resistance Level | $4.92 | $0.52 |
| Average True Range (ATR) | 0.36 | 0.05 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 1.93 | 6.18 |
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.